Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 68INDUSTRY 22NIH 10OTHER_GOV 5NETWORK 4UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colonic Neoplasms 1

Interventions

S 1 (combination) 11titanium silicide 5Oxaliplatin 5Cisplatin 3nimotuzumab 2Surgical Procedures, Operative 2Docetaxel 2toripalimab 1raltitrexed 1pembrolizumab 1Trastuzumab 1Taxes 1Radiotherapy, Intensity-Modulated 1Paclitaxel 1Irinotecan 1Injections 1Chemotherapy, Adjuvant 1Capecitabine 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Stomach Neoplasms × Irinotecan × Clear all
NCT01444521 2014-05-06

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

ChineseAMS

Phase 2 Completed
50 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡